MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 67.25 EUR 0.37% Market Closed
Market Cap: 2.5B EUR

Intrinsic Value

The intrinsic value of one MOR stock under the Base Case scenario is 16.41 EUR. Compared to the current market price of 67.25 EUR, MorphoSys AG is Overvalued by 76%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MOR Intrinsic Value
16.41 EUR
Overvaluation 76%
Intrinsic Value
Price
Base Case Scenario

Valuation History
MorphoSys AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MOR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MOR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

MorphoSys AG
XETRA:MOR
DE
Biotechnology
Market Cap
2.5B EUR
IPO
Mar 9, 1999
DE
Biotechnology
Market Cap
2.5B EUR
IPO
Mar 9, 1999
Price
false
EPS
false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about MorphoSys AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
MorphoSys AG

Current Assets 675m
Cash & Short-Term Investments 630.8m
Receivables 30.8m
Other Current Assets 13.4m
Non-Current Assets 1.2B
Long-Term Investments 2.1m
PP&E 11m
Intangibles 1.1B
Other Non-Current Assets 7.3m
Efficiency

Free Cash Flow Analysis
MorphoSys AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MorphoSys AG

Revenue
203.5m EUR
Cost of Revenue
-32.8m EUR
Gross Profit
170.7m EUR
Operating Expenses
-611.1m EUR
Operating Income
-440.4m EUR
Other Expenses
-19.9m EUR
Net Income
-460.3m EUR
Fundamental Scores

MOR Profitability Score
Profitability Due Diligence

MorphoSys AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
ROE is Increasing
49/100
Profitability
Score

MorphoSys AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

MOR Solvency Score
Solvency Due Diligence

MorphoSys AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
39/100
Solvency
Score

MorphoSys AG's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOR Price Targets Summary
MorphoSys AG

There are no price targets for MOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

MorphoSys AG
does not pay dividends
Shareholder Yield

Current shareholder yield for MOR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MOR Insider Trading
Buy and sell transactions by insiders

MOR News

Other Videos
What is the Intrinsic Value of one MOR stock?

The intrinsic value of one MOR stock under the Base Case scenario is 16.41 EUR.

Is MOR stock undervalued or overvalued?

Compared to the current market price of 67.25 EUR, MorphoSys AG is Overvalued by 76%.

Back to Top